A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs AEG 33773 (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors Aegera Therapeutics
- 28 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 May 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.